Thousands sign up to large-scale COVID-19 trial in UK

Thousands of patients have signed up in a few days to support a large-scale NHS trial for potential treatments for COVID-19 in the UK, one of the countries worst hit by the global pandemic.

AbbVie won’t enforce patents for COVID-19 drug candidate Kal...

New combination trial firms up Venclexta’s prospects in AML

AbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scien...

AbbVie/Allergan merger cleared in EU with brazikumab sell-of...

AbbVie and Allergan’s $63 billion merger has been cleared by European regulators, who have approved the sell-off of pipeline gastrointestinal autoimmune diseases drug brazikumab to AstraZen

AbbVie/Roche's Venclexta fails in confirmatory AML trial

AbbVie and Roche's Venclexta has failed to significantly improve overall survival in an acute myeloid leukaemia (AML) trial that was supposed to confirm its efficacy.